tariquidar tariquidar tariquidar (inn/usan) is a p-glycoprotein inhibitor undergoing research as an adjuvant against multidrug resistance in cancer. tariquidarclinical dataatc codenoneidentifiers iupac name n-phenyl]carbamoyl]-4,5-dimethoxyphenyl]quinoline-3-carboxamide cas number206873-63-4 ypubchem cid148201chemspider130650 nuniij58862dtvdchemblchembl348475 ncomptox dashboard (epa)dtxsid10174746 chemical and physical dataformulac38h38n4o6molar mass646.744 g·mol−13d model (jsmol)interactive image smiles coc1=c(c=c2cn(ccc2=c1)ccc3=cc=c(c=c3)nc(=o)c4=cc(=c(c=c4nc(=o)c5=cc6=cc=cc=c6n=c5)oc)oc)oc inchi inchi=1s/c38h38n4o6/c1-45-33-18-25-14-16-42(23-28(25)19-34(33)46-2)15-13-24-9-11-29(12-10-24)40-38(44)30-20-35(47-3)36(48-4)21-32(30)41-37(43)27-17-26-7-5-6-8-31(26)39-22-27/h5-12,17-22h,13-16,23h2,1-4h3,(h,40,44)(h,41,43) nkey:lgghdpfkssrqns-uhfffaoysa-n n ny (what is this?) (verify)